Regeneron’s Adam Gastonguay shares how to raise the profile of your IP team, get the most from outside counsel, and stay ahead of the growing pressure to adopt AI. If you don't have a login or your ...
Inconsistent Bolar interpretations and tougher trial disclosures are tightening the squeeze on innovators in life sciences, counsel told LSPN Europe. Tom Phillips reports. If you don't have a login or ...
16 January 2025 A district court of appeal has paused MSN Pharmaceuticals’ launch | Result comes days after the Federal ...
US Federal Trade Commission’s antitrust warning tipped the scales in Pfizer’s favour, ending a heated dispute over a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback